Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.
about
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsNeurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's diseaseRisk of surgical delivery to deep nuclei: a meta-analysisPrevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersIntraspinal transplantation of motoneuron-like cell combined with delivery of polymer-based glial cell line-derived neurotrophic factor for repair of spinal cord contusion injury.Stem cell therapy: a new approach to the treatment of refractory depression.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.An Update on Fetal Alcohol Syndrome-Pathogenesis, Risks, and Treatment.Neural stem cells for Parkinson's disease: to protect and repair.Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?Stem cell therapy: social recognition recovery in a FASD model.Submandibular gland biopsy for the diagnosis of Parkinson diseaseBehavior of hippocampal stem/progenitor cells following grafting into the injured aged hippocampusOlfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.Ambiguous cells: the emergence of the stem cell concept in the nineteenth and twentieth centuries.Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.Rethinking risk assessment for emerging technology first-in-human trials.Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges.Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging.Ethical implications in the use of embryonic and adult neural stem cells.Effects of atelocollagen on neural stem cell function and its migrating capacity into brain in psychiatric disease model.Cell transplantation and gene therapy in Parkinson's disease.Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease.What's missing? Discussing stem cell translational research in educational information on stem cell "tourism".Scare-mongering and the anticipatory ethics of experimental technologies.Ethical challenges to cell-based interventions for the central nervous system: some recommendations for clinical trials and practice.Dissociations in the meaning of risk between health-care professionals and individuals with spinal cord injury.Challenges to Ethically Managing Parkinson Disease: An Interview Study of Patient Perspectives.Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertaintySelling Translational Research: Is Science a Value-Neutral Autonomous Enterprise?Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the BrainEthical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease
P2860
Q24289526-017C34A4-DAC3-459D-A724-E745CF4C4027Q27012533-759091A2-FE02-43F8-994E-4BC486763E3AQ30371423-F11B3FD1-BD91-4B07-A41D-B64D52BDF327Q33874572-A02DAB54-767F-4320-879B-D79C54F7F3C5Q34096316-ADFE9F7D-7C43-4838-9155-391731A843E6Q34215946-07BD216C-EB0E-476A-88DE-B96539466B0BQ34240433-46E02120-203F-4D5A-8EC6-C0C5FC8C2B3DQ34532819-9CC4E3FD-75A0-4865-A14F-F8B208C741D4Q35901261-DF28D226-0DA5-444C-9980-97136945DE7AQ36264251-9C7E767F-A3FE-4872-8940-903E54412F86Q36591255-3896C9C2-9FB9-4ECB-8845-50859917B546Q36607622-CCA16C22-6674-4289-B076-F3532DB7D118Q36953710-FF88E6F9-ECCE-4D74-B3A7-384D90596309Q37073141-30B1E279-F97D-4826-8CB3-6AECB65C60D7Q37221734-1F6A63A1-0639-4B88-B967-02F1D4217E0AQ38873789-66C2ACCB-E82F-404D-991A-26C3D537A0AAQ38974025-6D624792-6FB4-4428-B47C-C6A56D7EDFDEQ39984564-4CA17054-5856-4B50-BFDC-90A26B1773EEQ40069509-04F5FC27-B99A-49F2-B5E7-E0595F286139Q41785924-874331DE-BD2E-4DD8-8D95-6AA259802863Q43686550-39C1DA91-82EE-4A43-B0A5-A557072399CAQ44297524-CA841E34-9F5B-441E-962C-1CC2FA9DBA8DQ45290606-B0F2B343-DAE6-41BA-A31A-0335EEF0354FQ46679832-1FB265E2-A27C-46D5-B670-1C44984BAEEAQ48643126-BD9F198B-1CA2-4AB3-BB84-E798EC326F8CQ48643159-6D15E81E-FAC9-4966-9E3F-C8FA4D60B9B0Q51783699-837D8DAC-1F1D-423A-AE1F-286C7280FE2AQ55014629-1F1670EC-D7F1-42F4-AFA7-5C6C375C0466Q56781809-06FC2489-1704-4909-BD24-D01C11FE1046Q57988439-69D2AFDD-F867-4011-A1D0-958078E31B29Q58255075-9FF57D1E-C51E-4798-BC4B-1C3FA8077984Q58281682-F756EA3A-C139-4F06-8238-482D6D736EE2
P2860
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@ast
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@en
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@nl
type
label
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@ast
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@en
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@nl
prefLabel
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@ast
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@en
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Benefits, risks and ethical co ...... ations in Parkinson's disease.
@en
P2093
Ivar Mendez
Marcus McLeod
Zubin Master
P2860
P304
P356
10.1136/JME.2005.013169
P577
2007-03-01T00:00:00Z